MYDA Advisors LLC Buys Shares of 40,200 Billiontoone, Inc. $BLLN

MYDA Advisors LLC bought a new stake in shares of Billiontoone, Inc. (NASDAQ:BLLN) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 40,200 shares of the company’s stock, valued at approximately $3,290,000. MYDA Advisors LLC owned 0.09% of Billiontoone as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the company. Adams Street Partners LLC acquired a new stake in Billiontoone during the 4th quarter valued at $140,063,000. Baillie Gifford & Co. acquired a new stake in Billiontoone during the 4th quarter valued at $103,786,000. JPMorgan Chase & Co. acquired a new stake in Billiontoone during the 4th quarter valued at $32,078,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Billiontoone during the 4th quarter valued at $18,631,000. Finally, Capital International Investors acquired a new stake in Billiontoone during the 4th quarter valued at $14,568,000.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Wells Fargo & Company cut their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 5th. Guggenheim upped their price target on shares of Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. BTIG Research dropped their price target on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Finally, Weiss Ratings downgraded shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Billiontoone has a consensus rating of “Moderate Buy” and an average target price of $125.29.

Insider Buying and Selling

In related news, insider Shan Riku Sakakibara sold 8,000 shares of the company’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $98.22, for a total value of $785,760.00. Following the completion of the sale, the insider directly owned 212,000 shares in the company, valued at approximately $20,822,640. This represents a 3.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the completion of the sale, the insider owned 21,900 shares of the company’s stock, valued at $2,200,293. This represents a 32.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 60,750 shares of company stock worth $5,979,598.

Billiontoone Stock Performance

NASDAQ BLLN opened at $101.12 on Monday. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $138.70. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $4.65 billion and a PE ratio of 183.85. The firm’s fifty day simple moving average is $88.03 and its 200-day simple moving average is $87.97.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. During the same period last year, the company posted ($0.39) earnings per share. The company’s revenue was up 83.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Billiontoone, Inc. will post 0.93 earnings per share for the current fiscal year.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.